Low-Carb Versus Mediterranean Diet in PCOS

NCT ID: NCT05272657

Last Updated: 2022-04-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

130 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-30

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a randomized controlled trial of two diets (low-carbohydrate and Mediterranean diet) in the treatment of women with polycystic ovary syndrome (PCOS). The trial assesses the effects of the two diets on clinical, metabolic and hormonal parameters, inflammatory markers and gut microbiota . This study is an interventional, randomized controlled trial, open-labeled.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study aims to clarify the impact of nutritional recommendations for women with polycystic ovary syndrome on clinical, metabolic and hormonal parameters, inflammatory markers and gut microbiota . Women with PCOS are randomized into 2 treatment groups: one group on a low-carbohydrate diet and the other on a Mediterranean diet. The adhearance to a prescribed diet will be controlled through food intake diaries using a mobile application with electronic reporting forms.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Polycystic Ovary Syndrome (PCOS)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

low-carbohydrate diet

subjects in this arm are given detailed instructions and coaching in following a low-carbohydrate diet.

Group Type EXPERIMENTAL

low-carbohydrate diet

Intervention Type OTHER

subjects in this arm are given detailed instructions and coaching in following a low-carbohydrate diet.

Mediterranean diet

subjects in this arm are given detailed instructions and coaching in following a Mediterranean diet.

Group Type EXPERIMENTAL

Mediterranean diet

Intervention Type OTHER

subjects in this arm are given detailed instructions and coaching in following a Mediterranean diet.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

low-carbohydrate diet

subjects in this arm are given detailed instructions and coaching in following a low-carbohydrate diet.

Intervention Type OTHER

Mediterranean diet

subjects in this arm are given detailed instructions and coaching in following a Mediterranean diet.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women with PCOS between the ages of 18-40 years and with a body mass index of less than or equal to 45.
* Fulfillment of at least two of the following three criteria for PCOS, adopted by the Rotterdam Consensus in 2003 (Rotterdam ESHRE / ASRM-Sponsored PCOS Consensus Workshop Group):

* signs of hyperandrogenemia - clinical and / or biochemical (increase in the index of free androgens or total testosterone)
* signs of chronic anovulation
* ultrasound signs: the number of follicles in the ovary ≥ 20 and / or ovarian volume ≥ 10 ml in any ovary in the case of gynecological age 8 or more years after menarche.

Exclusion Criteria

* The presence of hyperprolactinemia
* Cushing's syndrome
* Ongenital hyperplasia of the adrenal cortex
* Hypothyroidism
* Androgen-producing tumors
* Regular use of drugs and dietary supplements that affect the function of the ovaries
* Adrenal glands
* Metabolism of carbohydrates
* Lipids
* Microbiota composition during the 2 months preceding the study
* Pregnancy
* Lactation
* Significant comorbidities
Minimum Eligible Age

18 Years

Maximum Eligible Age

44 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Polina Popova, MD,PhD

Role: STUDY_CHAIR

Almazov National Medical Research Centre

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Polina Popova, MD,PhD

Role: CONTACT

702-55-95 ext. 007(812)

Elena Vasiukova

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pcos2typesofDiet

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS)
NCT05646199 NOT_YET_RECRUITING PHASE2/PHASE3